NCT05296278 2024-01-10
Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC
Hunan Province Tumor Hospital
Phase 2 Unknown
Clinical Trials
5 trialsNCT04338620 2023-03-06
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Tang-Du Hospital
Phase 2 Unknown
NCT01951469 2022-03-08
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT04970043 2021-07-21
Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
NCT02031601 2016-03-29
TCL-1
Qilu Hospital of Shandong University
Phase 4 Unknown